MPS I
8 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Safety and Efficacy of Encapsulated Allogeneic MPS-1 Therapy (NCT05665036) | Sigilon Therapeutics, Inc. | 2021-11-15 |
| The Intensively Follow-up Examinations for Asymptomatic MPS I Infants in Taiwan (NCT04958070) | Mackay Memorial Hospital | 2021-09-15 |
| PEARL (PrEnAtal Enzyme Replacement Therapy for Lysosomal Storage Disorders) (NCT04532047) | University of California, San Francisco | 2021-07-01 |
| Ultrasound Findings of Finger, Wrist and Knee Joints in Mucopolysaccharidosis (NCT02067650) | Children's Hospital of Eastern Ontario | 2013-09-01 |
| Laronidase (Aldurazyme TM) Enzyme Replacement Therapy With Hematopoietic Stem Cell Transplant for Hurler Syndrome (NCT01572636) | Masonic Cancer Center, University of Minnesota | 2012-03-28 |
| Longitudinal Study of Neurodegenerative Disorders (NCT03333200) | University of Pittsburgh | 2012-01-11 |
Track MPS I automatically
Every clearance here is in the API, with alerts when new ones post.